Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tingting Zhang, Jinqiu Rao, Wei Li, Kai Wang & Feng Qiu. (2020) Mechanism-based inactivation of cytochrome P450 enzymes by natural products based on metabolic activation. Drug Metabolism Reviews 52:4, pages 501-530.
Read now
Read now
Kai Wang, Qing Gao, Tingting Zhang, Jinqiu Rao, Liqin Ding & Feng Qiu. (2020) Inhibition of CYP2C9 by natural products: insight into the potential risk of herb-drug interactions. Drug Metabolism Reviews 52:2, pages 235-257.
Read now
Read now
Bo Wen & Peter Gorycki. (2019) Bioactivation of herbal constituents: mechanisms and toxicological relevance. Drug Metabolism Reviews 51:4, pages 453-497.
Read now
Read now
Yifeng Zhou, Liling Wang, Yuchuan Qin, Lichun Chen, Qing Ge & Jianwei Mao. (2018) A sequential separation of linderane and norisoboldine using supercritical fluid and ionic liquid-based ultrasonic-assisted extraction from Lindera aggregate. Separation Science and Technology 53:18, pages 2916-2925.
Read now
Read now
Articles from other publishers (15)
Yi Tao, Yuling Deng & Ping Wang. (2024) Traditional uses, phytochemistry, pharmacology, processing methods and quality control of Lindera aggregata (Sims) Kosterm: A critical review. Journal of Ethnopharmacology 318, pages 116954.
Crossref
Crossref
Ting Peng, Jinqiu Rao, Tingting Zhang, Yuan Wang, Na Li, Qing Gao, Xinchi Feng, Zhaohui Song, Kai Wang & Feng Qiu. (2023) Elucidation of the relationship between evodiamine-induced liver injury and CYP3A4-mediated metabolic activation by UPLC-MS/MS analysis. Analytical and Bioanalytical Chemistry.
Crossref
Crossref
Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen & Yongjie Zhang. (2023) Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9. Drug Metabolism and Disposition 51:6, pages 771-781.
Crossref
Crossref
Yi Zhang, Binhao Cai, Yingying Li, Ying Xu, Yuhan Wang, Lulu Zheng, Xiaochun Zheng, Lina Yin, Gaozhi Chen, Yunxiang Wang, Guang Liang & Lingfeng Chen. (2023) Identification of linderalactone as a natural inhibitor of SHP2 to ameliorate CCl4-induced liver fibrosis. Frontiers in Pharmacology 14.
Crossref
Crossref
Guode Zhao, Yufei Ma, Xu Wang, Wei Li, Yuqin Chen, Weiwei Li, Ying Peng & Jiang Zheng. (2022) Configurational Alteration Results in Change in Hepatotoxicity of Asarone. Journal of Agricultural and Food Chemistry 71:1, pages 884-894.
Crossref
Crossref
Qinger Huang, Xiaojie Yan, Rongjun Liao, Kaohua Liu, Luping Qin & Bo Zhu. (2023) <i>Lindera aggregata</i> (Sims) Kosterm: A Systematic Review of its Traditional Applications, Phytochemical and Pharmacological Properties, and Quality Control. Medicinal Plant Biology 0:0, pages 0-0.
Crossref
Crossref
Hong Pan, Lin Chen, Guohong Zhai, Qi Luo, Chao Fang & Fuguo Shi. (2022) Feature MS fragments-based method for identification of toxic furanoids in biological samples. Journal of Pharmaceutical and Biomedical Analysis 221, pages 115035.
Crossref
Crossref
Tingting Zhang, Ting Peng, Jinqiu Rao, Kai Wang & Feng Qiu. (2022) Quantitation of Diclofenac, Tolbutamide, and Warfarin as Typical CYP2C9 Substrates in Rat Plasma by UPLC-MS/MS and Its Application to Evaluate Linderane-Mediated Herb-Drug Interactions. Journal of Analytical Methods in Chemistry 2022, pages 1-11.
Crossref
Crossref
Kai Wang, Tingting Zhang, Jinqiu Rao, Ting Peng, Qing Gao, Xinchi Feng & Feng Qiu. (2022) Drug-drug interactions induced by Linderane based on mechanism-based inactivation of CYP2C9 and the molecular mechanisms. Bioorganic Chemistry 118, pages 105478.
Crossref
Crossref
Zhihai Ke & Ying-Yeung Yeung. 2022. Comprehensive Heterocyclic Chemistry IV. Comprehensive Heterocyclic Chemistry IV
412
449
.
Ying Liu, Shiyu Zhang, Tingting Jiang, Rong Tan, Yao Fu, Xiaojing Yang, Bowen Gong, Ying Zou, Weiwei Li & Jiang Zheng. (2021) Mechanistic study of bergamottin-induced inactivation of CYP2C9. Food and Chemical Toxicology 153, pages 112278.
Crossref
Crossref
Tingting Jiang, Ting Cheng, Jing Li, Mengyue Zhou, Rong Tan, Xiaojing Yang, Yang Wang, Weiwei Li & Jiang Zheng. (2020) Bergaptol, a mechanism-based inactivator of CYP2C9. Medicinal Chemistry Research 29:7, pages 1230-1237.
Crossref
Crossref
Haijun Zhang, Chunping Zhu, Zhe Sun, Xiaoguang Yan, Huihui Wang, Haibo Xu, Jiani Ma & Yanrong Zhang. (2019) Linderane protects pancreatic β cells from streptozotocin (STZ)-induced oxidative damage. Life Sciences 233, pages 116732.
Crossref
Crossref
Wei Xie, Yangliang Ye, Ying Feng, Tifei Xu, Suling Huang, Jianhua Shen & Ying Leng. (2018) Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3. Frontiers in Pharmacology 9.
Crossref
Crossref
Ole Kristian Forstrønen Thu, Olav Spigset & Bent Hellum. (2017)
Noncompetitive inhibition of human CYP2C9 in vitro by a commercial
Rhodiola rosea
product
. Pharmacology Research & Perspectives 5:4, pages e00324.
Crossref
Crossref